Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Ovarian Cancer, Ovarian Neoplasms”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableStudy completedNCT02852447
What this trial is testing

The Effect of Surgery for Non Endometriosic Ovarian Cysts on Ovarian Reserve

Who this might be right for
Antimullerian HormoneOvarian CystsAntral Follicle Count
Corporacion Parc Tauli 30
Testing effectiveness (Phase 2)Active Not RecruitingNCT04274426
What this trial is testing

Mirvetuximab Soravtansine (IMGN853), in Folate Receptor Alpha (FRα) High Recurrent Ovarian Cancer

Who this might be right for
Recurrent Epithelial Ovarian, Fallopian or Peritoneal Carcinoma
AGO Research GmbH 136
Early research (Phase 1)Study completedNCT00028535
What this trial is testing

Interleukin-12, Paclitaxel, and Trastuzumab in Treating Patients With Solid Tumors

Who this might be right for
Male Breast CancerRecurrent Breast CancerRecurrent Endometrial Carcinoma+4 more
National Cancer Institute (NCI) 18
Early research (Phase 1)Study completedNCT03085225
What this trial is testing

Trabectedin Combined With Durvalumab in Patients With Advanced Pretreated Soft-tissue Sarcomas and Ovarian Carcinomas.

Who this might be right for
Ovarian CarcinomaSoft Tissue Sarcoma
Institut Bergonié 40
Early research (Phase 1)Study completedNCT03332576
What this trial is testing

Phase 1b Study of a Cancer Vaccine to Treat Patients With Advanced Stage Ovarian, Fallopian or Peritoneal Cancer

Who this might be right for
Epithelial Ovarian CancerFallopian Tube CancerPeritoneal Cancer
ImmunoVaccine Technologies, Inc. (IMV Inc.) 37
Early research (Phase 1)Study completedNCT00652691
What this trial is testing

Topotecan, High-Dose Cyclophosphamide, Carboplatin, and an Autologous Peripheral Blood Cell Transplant in Treating Patients With Recurrent Ovarian Cancer or Primary Peritoneal Cancer

Who this might be right for
Ovarian CancerPeritoneal Cavity Cancer
Mayo Clinic 48
Early research (Phase 1)Study completedNCT02260544
What this trial is testing

Bioequivalence Study of Doxorubicin Hydrochloride Liposome Injection

Who this might be right for
Ovarian Epithelial Cancer Recurrent
Dr. Reddy's Laboratories Limited 49
Not applicableStudy completedNCT05377021
What this trial is testing

Lifestyle Change in Women With Polycystic Ovary Syndrome

Who this might be right for
Polycystic Ovary Syndrome
Dokuz Eylul University 27
Large-scale testing (Phase 3)UnknownNCT03709316
What this trial is testing

ZL-2306 (Niraparib) as Maintenance Treatment Following First-line Chemotherapy in Patients With Advanced Ovarian Cancer

Who this might be right for
Ovarian Cancer
Zai Lab (Shanghai) Co., Ltd. 384
Testing effectiveness (Phase 2)Study completedNCT00314678
What this trial is testing

Cisplatin Induction With Paclitaxel Consolidation for Stage III-IV Epithelial Ovarian and Primary Peritoneal Cancer

Who this might be right for
Epithelial Ovarian CancerPrimary Peritoneal Cancer
John P. Fruehauf 40
Not applicableStudy completedNCT06958068
What this trial is testing

Sexual Health Integration in Treatment of Gynecological Oncology

Who this might be right for
Ovarian CancerEndometrial CancerCervical Cancers+3 more
Medical University of Silesia 324
Large-scale testing (Phase 3)UnknownNCT00657878
What this trial is testing

Efficacy Study of Chemotherapy to Treat Ovarian Cancer Recurrence by Prolonging the Platinum Free Interval

Who this might be right for
Ovarian Cancer
National Cancer Institute, Naples 215
Testing effectiveness (Phase 2)Study completedNCT03578497
What this trial is testing

Effects of Interleukin-1 Receptor Antagonism on Hyperandrogenemia in Women With Polycystic Ovary Syndrome

Who this might be right for
Polycystic Ovary Syndrome
University Hospital, Basel, Switzerland 18
Not applicableUnknownNCT02516540
What this trial is testing

Efficacy of Lifestyle Intervention in BRCA1/2 Mutation Carriers

Who this might be right for
Hereditary Breast and Ovarian Cancer
Technical University of Munich 600
Testing effectiveness (Phase 2)Study completedNCT05708950
What this trial is testing

A Clinical Trial of KVA12123 [TBS-2025] Treatment Alone and in Combination With Pembrolizumab In Advanced Solid Tumors (VISTA-101)

Who this might be right for
CancerSolid TumorMelanoma+14 more
Kineta Inc. 40
Large-scale testing (Phase 3)Study completedNCT00066690
What this trial is testing

Suppression of Ovarian Function With Either Tamoxifen or Exemestane Compared With Tamoxifen Alone in Treating Premenopausal Women With Hormone-Responsive Breast Cancer

Who this might be right for
Estrogen Receptor Positive Breast CancerProgesterone Receptor Positive TumorRecurrent Breast Carcinoma+5 more
ETOP IBCSG Partners Foundation 3,066
Not applicableStudy completedNCT00005459
What this trial is testing

Risk of Coronary Heart Disease in Women With Polycystic Ovary Syndrome

Who this might be right for
AtherosclerosisCardiovascular DiseasesHeart Diseases+3 more
National Heart, Lung, and Blood Institute (NHLBI)
Testing effectiveness (Phase 2)Study completedNCT00239980
What this trial is testing

Fragmin in Ovarian Cancer: Utility on Survival (FOCUS)

Who this might be right for
Ovarian Cancer
Ontario Clinical Oncology Group (OCOG) 77
Early research (Phase 1)Study completedNCT07399535
What this trial is testing

Clinical Investigation of Herbal Formulation and Its Efficacy in Polycystic Ovarian Syndrome

Who this might be right for
Polycystic Ovarian Syndrome (PCOS)Herbal MedicineInfertility+1 more
Jinnah Postgraduate Medical Centre 116
Testing effectiveness (Phase 2)Looking for participantsNCT06677190
What this trial is testing

Belzutifan in Recurrent Clear Cell Carcinoma of Gynecologic Origin

Who this might be right for
Ovarian CancerOvarian CarcinomaEndometrial Cancer+5 more
Dana-Farber Cancer Institute 32
Next Page